Your session is about to expire
← Back to Search
Cognitive Behavioral Therapy for Insomnia (STRIDE Trial)
STRIDE Trial Summary
This trial will test whether a digital cognitive behavioral therapy for insomnia followed by a face-to-face CBT-I is more effective in improving insomnia and sleep outcomes than just the digital therapy alone.
STRIDE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.STRIDE Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with major depression.I am currently taking antidepressants for depression.You have no clinically significant depressive symptoms.You have insomnia (ISI > 14).I have a sleep disorder other than insomnia.I am under 18 years old.I have been diagnosed with bipolar disorder or a seizure disorder.
- Group 1: Attention Control
- Group 2: Stepped Care Model
- Group 3: digital CBT-I
- Group 4: Stepped Care Model Control
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: You will receive the treatment for 3 null
- Follow Ups: You may be asked to continue sharing information regarding the trial for 3 Months after you stop receiving the treatment.
Frequently Asked Questions
Are participants still being accepted into this study?
"Yes, according to clinicaltrials.gov this research study is still seeking participants. This trial was first made available on the 9th of March 2018 and most recently revised on the 7th of February 2022."
What are the ambitions of this exploration?
"The primary aim of this clinical trial, which will be evaluated over the course of 1 and 2 years post randomization, is to assess the efficiency of dCBT-I/CBT-I for insomnia relief. The secondary objectives comprise ascertaining if race plays a role in depression prevention with stepped care treatment (self reported by patients), determining the mediation of depression avoidance through reducing rumination on a transdiagnostic level (as determined by Perseverative Thinking Questionnaire scores ranging from 15 - 75) and examining whether depressive rumination can mediate such prevention as established via Rumination Response Scale scores between 22 - 88)."
What is the sample size of this experiment?
"Affirmative. The records posted to clinicaltrials.gov show that this medical research, which was originally published on March 9th 2018, is currently enrolling volunteers. An estimated 1000 patients are being sought from 1 particular healthcare centre."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- Henry Ford Medical Center - Columbus: < 24 hours
Average response time
- < 1 Day
Share this study with friends
Copy Link
Messenger